Arman J. Kuyumjian > Baker Botts L.L.P. > New York, United States > Lawyer Profile
Baker Botts L.L.P. Offices
30 ROCKEFELLER PLAZA
NEW YORK, NEW YORK 10112-4498
NEW YORK
United States
- Firm Profile
- Go to...
Arman J. Kuyumjian
Work Department
Corporate
Position
Partner
Career
Arman Kuyumjian is the Co-Head of the firm’s Cross-Border M&A Practice and a partner based in New York in the firm’s Corporate Practice Group. Mr. Kuyumjian focuses his practice on mergers and acquisitions, private equity, venture capital, joint ventures and other strategic alliances.
Mr. Kuyumjian has significant experience representing public and private companies, as well as private equity funds, in mergers and acquisitions, distressed and cross-border transactions. He also provides counsel on corporate governance, shareholder activism, defensive measures and other strategic considerations.
He represents local and multinational clients in the pharmaceutical, life sciences, transportation, banking, asset management, communications, high-tech, energy and real estate industries.
Prior to joining Baker Botts, Mr. Kuyumjian led corporate transactions for an international law firm in its New York office.
Memberships
New York State Bar
American Bar Association
Education
Bachelor of Laws, University of Western Ontario 1999
Bachelor of Commerce, McGill University 1996
Top Tier Firm Rankings
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- International Trade > Customs, export controls and economic sanctions
Firm Rankings
- Antitrust > Cartel
- Energy > Energy litigation: electric power
- Energy > Energy regulation: electric power
- Energy > Energy regulation: oil and gas
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Antitrust > Merger control
- Intellectual property > Patents: licensing
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Tax > US taxes: contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Civil litigation/class actions: defense
- Labor and employment > ERISA litigation
- Dispute resolution > International arbitration
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Patents: litigation (International Trade Commission)
- Energy > Renewable/alternative power
- Dispute resolution > Securities litigation: defense
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Finance > Capital markets: equity offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > General commercial disputes
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Finance > Project finance
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: non-contentious
- Real estate > Construction (including construction litigation)
- Healthcare > Life sciences
- Real estate > Real estate
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Dispute resolution > Corporate investigations and white-collar criminal defense